Second-trimester double or triple screening for Down syndrome: A comparison of Chinese and Caucasian populations

被引:29
|
作者
Wang, Yuan-Yuan
Luo, Jun
Zhu, Ming-Wei
Liu, Lan-Nv
Ma, Xu
机构
[1] Natl Res Inst Family Planning, WHO Collaborating Ctr Res Human Reprod, Beijing 100081, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Beijing 100037, Peoples R China
[3] Int Peace Hosp Protect Mother & Childs Hlth, China Welf Inst, Shanghai, Peoples R China
[4] Fudan Univ, Obstet & Gynecol Hosp, Med Ctr, Shanghai 200433, Peoples R China
[5] Maternal & Fetal Hlth Hosp, Shanghai, Peoples R China
关键词
Down syndrome; prenatal screening; alpha fetoprotein; human chorionic gonadotrophin; unconjugated estriol;
D O I
10.1016/j.ijgo.2006.04.030
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To compare the performance of double screening (measuring maternal serum levels of a-fetoprotein [AFP] and total beta-human chorionic gonadotrophin [hCG] as markers for Down syndrome) with that of triple screening (also measuring levels of unconjugated estriol [uE3]) in the second trimester of pregnancy, and to compare ethnic variance between Chinese and Caucasian populations. Methods: The study investigated 15096 normal singleton pregnancies and 24 pregnancies affected with Down syndrome. Frequency distributions of AFP, hCG, and uE3 levels were analyzed. Likelihood ratios (LRs) were calculated using the multiple of median value (MoM) of AFP, hCG, and uE3 as variables. After multiplying maternal age risk by the LR values for the markers used in double and triple screening, the specific risks obtained with double and triple screening were estimated. The detection rate (DR) and false-positive rate (FPR) were calculated at different cut-off points. The serum markers' levels were also compared with those of Caucasian women. Results: The median MoM value of hCG was higher in women with affected pregnancies (1.40) than those with unaffected pregnancies (1.00). However, the median MoMs of AFP and uE3 (0.79 and 0.68) were lower in affected than in unaffected pregnancies. At a FPR of 5%, the detection rates reached with double and triple screening were 50% and 66.7%, respectively. Ratios of the 3 serum markers' medians to those in a study with Caucasian women were 1.06 (range = 1.04-1.09) for AFP, 1.14 (range = 1.10-1.17) for hCG, and 1.28 (range = 1.23-1.41) for uE3 for the relevant gestational weeks. Conclusion: Triple screening performed better than double screening in the second trimester. Ethnic variance should be taken into account in Down syndrome screening. (c) 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 50 条
  • [31] Effect of smoking status on inhibin-A in second-trimester prenatal screening for Down syndrome
    Huttly, Wayne
    Bestwick, Jonathan
    Wald, Nicholas
    PRENATAL DIAGNOSIS, 2014, 34 (04) : 406 - 407
  • [32] Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity
    Muller, FO
    Dreux, S
    Dupoizat, H
    Uzan, S
    Dubin, MF
    Oury, JF
    Dingeon, B
    Dommergues, M
    PRENATAL DIAGNOSIS, 2003, 23 (04) : 331 - 335
  • [33] Interference in the autoDELFIA® hAFP immunoassay and effect on second-trimester Down's syndrome screening
    Mannings, Leanne
    Trow, Sandy
    Newman, Janet
    Nix, Barry
    Evans, Carol
    ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 : 438 - 440
  • [34] First- and Second-Trimester ADAM12s in Down Syndrome Screening
    Baviera, Giovanni
    Chimicata, Saveria
    De Domenico, Roberta
    Granese, Roberta
    Carbone, Camillo
    Dugo, Nella
    D'Anna, Rosario
    CLINICAL CHEMISTRY, 2010, 56 (08) : 1355 - 1357
  • [35] FIRST-AND SECOND-TRIMESTER DOWN SYNDROME SCREENING: CURRENT STRATEGIES AND CLINICAL GUIDELNES
    Tsai, Horng-Jyh
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2008, 47 (04): : 478 - 479
  • [36] Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population
    Rozenberg, Patrick
    Bussieres, Laurence
    Chevret, Sylvie
    Bernard, Jean Pierre
    Malagrida, Lydia
    Cuckle, Howard
    Chabry, Chantal
    Durand-Zaleski, Isabelle
    Bidat, Laurent
    Lacroix, Isabelle
    Moutis, Max
    Roger, Marc
    Jacquemot, Christine
    Bault, Jean Philippe
    Boukobza, Philippe
    Boccara, Patrick
    Vialard, Francois
    Giudicelli, Yves
    Ville, Yves
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (05) : 1379 - 1387
  • [37] Second-trimester biochemical screening
    Evans, MI
    O'Brien, JE
    Dvorin, E
    Harrison, H
    Bui, TH
    CLINICS IN PERINATOLOGY, 2001, 28 (02) : 289 - +
  • [38] First- and second-trimester evaluation of risk for down syndrome
    Skotko, Brian G.
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (06): : 1426 - 1426
  • [39] First- and second-trimester evaluation of risk for Down syndrome
    Ball, Robert H.
    Caughey, Aaron B.
    Malone, Fergal D.
    Nyberg, David A.
    Comstock, Christine H.
    Saade, George R.
    Berkowitz, Richard L.
    Gross, Susan J.
    Dugoff, Lorraine
    Craigo, Sabrina D.
    Timor-Tritsch, Ilan E.
    Carr, Stephen R.
    Wolfe, Honor M.
    Emig, Danielle
    D'Alton, Mary E.
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (01): : 10 - 17
  • [40] Rethinking second-trimester Down-syndrome screening in the cell-free DNA era
    Cuckle, H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2019, 54 (04) : 431 - 436